Skip to main content

Roundup's Primary Glyphosate Safe To Use Assures EPA

Roundup's Primary Glyphosate Safe To Use Assures EPA

Roundup's Primary Glyphosate Safe To Use Assures EPA

Introduction

EPA recently announced over the usage of Glyphosate that it doesn't cause cancer.

According to the review, glyphosate is the most-used herbicide in the U.S and meets the standard in the Federal Insecticide, Fungicide, and Rodenticide Act. It is one of the primary ingredients of Roundup. The California Office of Environmental Health Hazard Assessment had included glyphosate on a list of carcinogenic chemicals based on the World Health Organization’s  International Agency for Research(IARC). EPA stated, it probably doesn't cause cancer and can be used with some fine adjustments; also, its testing methods are more superior than IARC's.

The first trial against Monsanto over Roundup was held last summer in state court in San Francisco, which ruled in favor of plaintiffs with $78 million. The second ended last month in federal court with an $80 million verdict, including $75 million in punitive damages. The third trial is ongoing.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!